keyboard_arrow_up

For Epigenetics Research, are you looking at collaborating with Pharma Companies?

With the recent advances in the application of epigenetics in drug discovery, disease diagnosis, nutrition and lifestyle, it is a topic of interest for all leading pharma companies and research institutes.
The Epigenetics Discovery Congress to be held in London on the 24 - 25 September 2015 will focus on the following areas of Epigenetics :
  • Latest update on the clinical trials of epigenetic drugs
  • Drug discovery in epigenetics with case studies
  • Epigenetic biomarkers
  • Models and mechanisms of epigenetic gene regulation
  • Inter - individual variation and inheritance of epigenetic states in mammals
  • Epigenetics in disease diagnosis and treatment
  • Epigenetic drift in ageing
 
Speaker Presentations by
  • GlaxoSmithKline (GSK)
  • Cellzome
  • Oryzon
  • Epizyme
  • Novartis
  • Erasmus University Rotterdams
  • Cancer Research UK
  • Celgene
  • SGC
  • The Babraham Institute
  • Cambridge Biomedical Centre
  • University of Oxford
  • Blizard Institute
  • Volition Rx

The Epigenetics Discovery Congress will provide a platform to meet with over 150 UK and International delegates working in the field of Epigenetics. Register today with 'MnM-EDC30' as your discount code to get an early bird discount of 15% on registration fees; offer expires 30th June 2015.


We look forward to welcoming you in September.
 
Warm Regards,

Oliver Smith
Marketing Manager | MnM Conferences
 
P.S : Please forward this to any colleagues who you feel may be interested in the congress.